| Pharmaceutical active ingredients: |
| Methaqualone |
| Available forms, composition and doses of Noctilene: |
| N / A |
| Noctilene medical category: |
| Human:Central nervous system depressantsHypnotics and sedatives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N05CM01 - Methaqualone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Nocceler | N-Cyclohexyl-2-Benzothiazolesulfenamide | Unidentified Pharmaceutical Company |
| Nocilon | Isoproturon | Unidentified Pharmaceutical Company |
| Nocrac AW | Ethoxyquin | Unidentified Pharmaceutical Company |
| Nocrack AW | Ethoxyquin | Unidentified Pharmaceutical Company |
| Noctan | Methyprylon | Unidentified Pharmaceutical Company |
| Noctinal | Butabarbital | Unidentified Pharmaceutical Company |
| Noctivane | Hexobarbital | Unidentified Pharmaceutical Company |
| Noctomin | Diphenhydramine | Unidentified Pharmaceutical Company |
| Noctone | Ranitidine | Unidentified Pharmaceutical Company |
| Noctosediv | Thalidomide | Unidentified Pharmaceutical Company |